Sophie Levesque

This inventor holds 10 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 4 EPO patents. Top assignees: Bellus Health Inc., Bhi Limited Partnership, Biochem Pharma Inc.. Active years: 2000-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sophie Levesque. Retrieved from https://idiyas.com/inventor/sophie-levesque

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 (Patent Applications = 3)

% Patents Active = 70.0

CIPO Patents = 2

EPO Patents = 4 (Patent Applications = 1)

Average Co-Inventor Count = 7.8

ph-index = 6

Forward Citations = 121(Granted Patents)

Location History:

Laval, CA (2000)
Mirabel, CA (2002 - 2021)

Company Filing History:

Bhi Limited Partnership

Years Active: 2000-2021

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11020360 - Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid (2021-06-01),

2. 10857109 - Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid (2020-12-08),

3. 10238611 - Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid (2019-03-26),

4. 9499480 - Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid (2016-11-22),

5. 8835654 - Method and compositions for treating amyloid-related diseases (2014-09-16),

6. 8748656 - Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid (2014-06-10),

7. 8044100 - Methods and compositions for treating amyloid-related diseases (2011-10-25),

8. 6605614 - [1,8] naphthyridine derivatives having antiviral activity (2003-08-12),

9. 6340690 - Antiviral methods using [1,8]naphthyridine derivatives (2002-01-22),

10. 6057314 - Low molecular weight bicyclic thrombin inhibitors (2000-05-02),

Title: The Innovative Contributions of Sophie Levesque

Introduction

Sophie Levesque is a prominent inventor based in Mirabel, Canada. She has made significant contributions to the field of pharmaceuticals, particularly in the development of methods and compounds for delivering essential compounds for medical use. With a total of 10 patents to her name, her work is paving the way for advancements in treatment options for various diseases.

Latest Patents

One of her latest patents focuses on methods, compounds, compositions, and vehicles for delivering 3-amino-1-propanesulfonic acid (3APS) in a subject, preferably a human subject. This invention encompasses compounds that will yield or generate 3APS, either in vitro or in vivo. Preferred compounds include amino acid prodrugs of 3APS, which are intended for use in the prevention and treatment of Alzheimer's disease. This innovative approach highlights her commitment to addressing critical health issues through scientific research.

Career Highlights

Throughout her career, Sophie has worked with notable companies such as Bellus Health Inc. and Biochem Pharma Inc. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Sophie has collaborated with esteemed colleagues, including Benoit Bachand and Xianqi Kong. These partnerships have further enhanced her research capabilities and have led to the development of innovative solutions in her field.

Conclusion

Sophie Levesque's contributions to the field of pharmaceuticals through her patents and collaborations demonstrate her dedication to innovation and improving healthcare outcomes. Her work continues to inspire future advancements in medical treatments.

Profile summary based on public USPTO records.